Lara Chalabreysse
Overview
Explore the profile of Lara Chalabreysse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1466
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Latiri M, Belhocine M, Smith C, Garnier N, Balducci E, Pinton A, et al.
J Pathol
. 2024 Sep;
264(3):284-292.
PMID: 39329449
T-lymphoblastic lymphoma (T-LBL) and thymoma are two rare primary tumors of the thymus deriving either from T-cell precursors or from thymic epithelial cells, respectively. Some thymoma subtypes (AB, B1, and...
2.
Cherpaz M, Meugnier E, Seillier G, Pozzi M, Pierrard R, Leboube S, et al.
Cardiovasc Diabetol
. 2024 Jul;
23(1):239.
PMID: 38978010
Background: Type 2 diabetes (T2D) is a frequent comorbidity encountered in patients with severe aortic stenosis (AS), leading to an adverse left ventricular (LV) remodeling and dysfunction. Metabolic alterations have...
3.
Thomas-de-Montpreville V, Chalabreysse L, Hofman V, de-Muret A, Sizaret D, Dubois R, et al.
Histol Histopathol
. 2024 May;
40(1):1-10.
PMID: 38725394
Micronodular arrangement of epithelial cells and lymphoid B-cell hyperplasia with follicles are both peculiar histological features in thymic tissue. Such features may especially occur in thymic epithelial tumors. The most...
4.
Basse C, Khalifa J, Thillays F, Le Pechoux C, Maury J, Bonte P, et al.
J Thorac Oncol
. 2024 Apr;
19(7):1095-1107.
PMID: 38608932
Introduction: Thymomas are rare intrathoracic malignancies that can relapse after surgery. Whether or not Post-Operative RadioTherapy (PORT) should be delivered after surgery remains a major issue. RADIORYTHMIC is an ongoing,...
5.
Molina T, Roden A, Szolkowska M, Shimizu S, Moreira A, Chalabreysse L, et al.
Lung Cancer
. 2024 Feb;
189:107479.
PMID: 38306885
Introduction: Pathologists are staging thymic epithelial tumors (TET) according to the 8th UICC/AJCC TNM system. Within the French RYTHMIC network, dedicated to TET, agreement on pathologic tumor stage (pT) among...
6.
Leonce C, Guerriau C, Chalabreysse L, Duruisseaux M, Couraud S, Brevet M, et al.
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958668
Targeting EGFR alterations, particularly the L858R (Exon 21) mutation and Exon 19 deletion (del19), has significantly improved the survival of lung cancer patients. From now on, the issue is to...
7.
Castaldo A, Delestrain C, Diesler R, Merveilleux du Vignaux C, Onnee M, Touraine R, et al.
ERJ Open Res
. 2023 Nov;
9(6).
PMID: 37936900
https://bit.ly/45OxF5E.
8.
Grolleau E, Candiracci J, Lescuyer G, Barthelemy D, Benzerdjeb N, Haon C, et al.
Biomolecules
. 2023 Aug;
13(8).
PMID: 37627320
The molecular profiling of circulating tumor DNA (ctDNA) is a helpful tool not only in cancer treatment, but also in the early detection of relapse. However, the clinical interpretation of...
9.
Cottin V, Blanchard E, Kerjouan M, Lazor R, Reynaud-Gaubert M, Taille C, et al.
Respir Med Res
. 2023 Apr;
83:101010.
PMID: 37087906
Background: The present article is an English-language version of the French National Diagnostic and Care Protocol, a pragmatic tool to optimize and harmonize the diagnosis, care pathway, management and follow-up...
10.
Hofman V, Heeke S, Bontoux C, Chalabreysse L, Barritault M, Bringuier P, et al.
JTO Clin Res Rep
. 2023 Jan;
4(2):100457.
PMID: 36718140
Introduction: Gene fusion testing of , , , , and exon 14 skipping mutations is guideline recommended in nonsquamous NSCLC (NS-NSCLC). Nevertheless, assessment is often hindered by the limited availability...